Negative staining for special AT-rich sequence-binding protein 2 (SATB2) and the absence of osteoid matrix further assist in distinguishing ES from other small round cell malignancies, such as mesenchymal chondrosarcoma and small-cell osteosarcoma [5]. This evidence concerns the gene SATB2 and small cell osteogenic sarcoma.